Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
254.60    0.80 (0.32%)
Bid:
254.40
Ask:
254.60
Spread: 0.20 (0.079%)
Market Cap: £2.52b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Serco selected for US Air Force training services

23 Sep 2025 07:00

RNS Number : 3195A
Serco Group PLC
23 September 2025
 

 

 

MT&S selected as sole provider for training and simulator services to US Air Force

 

23 September 2025

 

MT&S, the mission training and satellite ground network communications software business acquired by Serco from Northrop Grumman, has been awarded a single-award indefinite delivery, indefinite quantity (IDIQ) contract by the US Air Force to provide enhanced simulator and training services. MT&S is the sole awardee under the programme which has a ceiling value of up to $972m (£720m) over five years, and is expected to generate revenue of around $60m (£45m) from task orders during 2026.

 

Under the Air Force Modelling and Simulation Support Services (AFMS3) programme, mission critical training systems and services at over 20 locations for the US Air Force will be delivered ensuring secure, efficient and advanced modelling and simulation capabilities. The programme will support synthetic training exercises, improve warfighter skills and enhance operational readiness.

 

This significant award in the defence sector follows the acquisition of MT&S and demonstrates Serco's strong position in the virtually enabled training and simulation support market.

 

Anthony Kirby, Serco Group Chief Executive, said:

"We are proud that MT&S has been selected to deliver the critically important AFMS3 contract for the US Air Force and are well positioned to deliver innovative, technology-enabled solutions which enhance training and maintain the highest levels of mission readiness for the US Armed Forces.

 

This contract award reflects our growing capabilities in mission simulation, operational training and Live, Virtual, Constructive technologies, which are key areas of strength and opportunity for Serco both in the US and internationally. It builds upon our momentum in defence, where we have deep expertise, from supporting personnel readiness to procurement, design & engineering, to deploying technology and ensuring well-maintained, modern infrastructure and assets for militaries around the world."

Ends.

 

For further information, please contact:

Jamie Hastings, Head of Investor Relations | +44 (0) 7718 195 074 | jamie.hastings@serco.com

Scot Marchbank, Group External Communications Director | +44 (0) 7958 675 706 | scot.marchbank@serco.com

 

 

About Serco

Serco brings together the right people, the right technology, and the right partners to create innovative solutions that make a positive impact and address some of the most urgent and complex challenges facing the modern world.

 

With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility, and customer services.

 

Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management.

 

Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery.

 

More information can be found at www.serco.com.

 

LEI: 549300PT2CIHYN5GWJ21

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFFRAVIFFIE
Date   Source Headline
5th Jun 20265:36 pmRNSTransaction in Own Shares
29th May 20265:35 pmRNSTransaction in Own Shares and Total Voting Rights
26th May 20267:00 amRNSSerco secures £270m contract from NNUH
22nd May 20265:14 pmRNSTransaction in Own Shares
15th May 20265:24 pmRNSTransaction in Own Shares
8th May 20265:25 pmRNSTransaction in Own Shares
30th Apr 20265:37 pmRNSTransactions in own shares and Total Voting Rights
24th Apr 20265:17 pmRNSTransactions in Own Shares
22nd Apr 20264:00 pmRNSResult of AGM
17th Apr 20265:34 pmRNSTransactions in Own Shares
10th Apr 20265:39 pmRNSTransactions in Own Shares
10th Apr 20263:46 pmRNSDirector/PDMR Shareholding
7th Apr 20265:35 pmRNSDirector/PDMR Shareholding
31st Mar 20265:21 pmRNSTransactions in Own Shares and Total Voting Rights
27th Mar 20263:03 pmRNSDirector/PDMR Shareholding
20th Mar 20265:50 pmRNSTransaction in Own Shares
18th Mar 20265:15 pmRNSHolding(s) in Company
18th Mar 202611:00 amRNSPublication of the 2025 ARA and 2026 Notice of AGM
13th Mar 20265:25 pmRNSTransaction in Own Shares
11th Mar 20265:46 pmRNSTransaction in Own Shares and Total Voting Rights
5th Mar 20267:02 amRNSShare Repurchase Programme
5th Mar 20267:00 amRNS2025 full year results
19th Feb 20265:45 pmRNSHolding(s) in Company
9th Feb 20265:30 pmRNSHolding(s) in Company
5th Feb 202612:30 pmRNSHolding(s) in Company
2nd Feb 20265:45 pmRNSTotal Voting Rights and Capital
29th Jan 20265:30 pmRNSHolding(s) in Company
5th Jan 20265:30 pmRNSHolding(s) in Company
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 20254:00 pmRNSHolding(s) in Company
19th Dec 20257:30 amRNSCancellation of Treasury Shares
19th Dec 20257:30 amRNSCancellation of Treasury Shares
17th Dec 20257:01 amRNSCFO Retirement
17th Dec 20257:00 amRNSSerco pre-close trading update
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:30 pmRNSBlock listing Interim Review
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSSerco awarded UK prison contract
28th Nov 20256:20 pmRNSTransactions in own shares and Total Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.